Alzamend Neuro ALZN
NASDAQ ALZN
$1.31 -0.04 (-2.96%)
At close: Nov 11, 2026 · 4:00 PM EST

Alzamend Neuro (ALZN) Net Preferred Shares Issued and Repurchased (2024 - 2026)

Updated

Alzamend Neuro's Net Preferred Shares Issued and Repurchased was $5.13 million in fiscal Q2 2025 (quarter ended Oct 31, 2024), up 161.0% from the prior quarter.

Analysis

Alzamend Neuro (ALZN) Net Preferred Shares Issued and Repurchased (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Alzamend Neuro 6.51 Mn -8.95 Mn - 7.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 7.35 Mn
Jul 31, 2025 5.76 Mn
Apr 30, 2025 647,500.00
Oct 31, 2024 6.50 Mn
Jul 31, 2024 624,770.00
Apr 30, 2024 950,000.00
API Access

Alzamend Neuro Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=ALZN&period=max&api_key=YOUR_API_KEY